Treadwell Allison A
Nephrology Nurse Practitioner, The Southeastern Permanente Group (TSPMG), Atlanta, GA.
Member of ANNA's Dogwood Chapter.
Nephrol Nurs J. 2017 Jul-Aug;44(4):295-307.
This study measured the prevalence of depression in 39 patients on hemodialysis and peritoneal dialysis in two urban outpatient facilities in the southeastern United States. Additionally, it evaluated the number of patients who sought and scheduled a mental health evaluation after screening and education. The prevalence of mild to severely depressed individuals among participants in this study was 36%, affirming previous findings of depressive symptoms in the ESRD population. Results suggest that patients with ESRD are at a higher risk for depression than the general population. The effects of depression may exacerbate ESRD symptoms, affect treatment adherence, and increase hospitalizations and morbidity. It is likely that screening, diagnosing, and treating depression will be associated with improvement in quality and quantity of life. The practicality of using the screening procedure may improve the detection of depression in this population. However, only a fraction of identified patients in this study pursued further mental health evaluation within the 45-day period. Continued research is needed to identify barriers to seeking mental health consultation and treatment in this community.
本研究在美国东南部两个城市门诊机构中,对39名接受血液透析和腹膜透析的患者的抑郁症患病率进行了测量。此外,还评估了在筛查和教育后寻求并安排心理健康评估的患者数量。本研究参与者中轻度至重度抑郁个体的患病率为36%,证实了先前在终末期肾病(ESRD)人群中关于抑郁症状的研究结果。结果表明,ESRD患者患抑郁症的风险高于普通人群。抑郁症的影响可能会加剧ESRD症状,影响治疗依从性,并增加住院率和发病率。筛查、诊断和治疗抑郁症可能会改善生活质量和数量。使用筛查程序的实用性可能会提高该人群中抑郁症的检出率。然而,在本研究中,只有一小部分确诊患者在45天内寻求了进一步的心理健康评估。需要持续开展研究,以确定该社区寻求心理健康咨询和治疗的障碍。